STOCK TITAN

Aeluma (ALMU) 10-Q Filings

ALMU NASDAQ

Here are the 10-Q quarterly reports from Aeluma, Inc. (ALMU) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow ALMU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALMU filings page.

Rhea-AI Summary

Aeluma, Inc. (ALMU) reported revenue of $568,000 for the three months ended September 30, 2026, down 59% from $1.385 million a year earlier. It attributed the decrease primarily to completion of the first phase of a large government contract, partially offset by revenue from four new government contracts. Net loss widened to $3.756 million from $1.493 million, while operating expenses rose 61% to $4.816 million. Net cash used in operating activities increased to $1.746 million from $815,000.

Cash and cash equivalents were $53.875 million as of September 30, 2026. Aeluma believes current cash, cash generated from operations and ATM capacity are sufficient to fund operations and capital expenditures for the next twelve months and beyond. The ATM program had $29.3 million remaining as of September 30, 2026, subject to applicable registration and offering limitations. On July 29, 2026, Aeluma entered a letter of intent with the U.S. Department of Commerce for up to $30 million in proposed funding, subject to due diligence and required government approvals; it is not a committed liquidity source. Disclosure controls and procedures were not effective, and a material weakness in financial reporting controls remained under remediation.

Rhea-AI Summary

Aeluma, Inc. reported higher revenue but a larger loss for the nine months ended March 31, 2026. Revenue rose to $3.9 million from $3.3 million, driven mainly by government contracts, while operating expenses more than doubled to $9.7 million as the company expanded headcount, materials purchases, and stock-based compensation.

Net loss widened to $5.1 million from $2.2 million, partly offset by other income of $668 thousand from interest on cash and investments. Cash, cash equivalents, and a certificate of deposit totaled $37.8 million as of March 31, 2026, up from $15.7 million, largely due to two underwritten equity offerings that raised net proceeds of $12.6 million and $23.4 million.

The company entered several new government contracts and had remaining performance obligations of $8.9 million, with revenue highly concentrated in U.S. government customers. Aeluma also put in place a $50 million at-the-market equity program that had not been utilized by quarter end. Management disclosed that disclosure controls and procedures remained ineffective due to limited finance staffing, although remediation efforts are underway.

Rhea-AI Summary

Aeluma, Inc. reported revenue of $2.7 million for the six months ended December 31, 2025, up from $2.1 million a year earlier, mainly from U.S. government contracts. Operating expenses rose sharply to $6.3 million, driven by higher materials costs and expanding headcount, leading to a net loss of $3.3 million, slightly better than the prior period’s $3.6 million loss.

The company strengthened its balance sheet with two underwritten equity offerings in March and September 2025, providing net proceeds of $12.6 million and $23.4 million. Cash, cash equivalents and a certificate of deposit increased to $38.6 million, and management states that prior substantial doubt about its ability to continue as a going concern has been alleviated for at least the next twelve months. However, disclosure controls and procedures were deemed not effective due to limited finance staffing, and remediation efforts, including hiring a new chief financial officer and adding accounting resources, are underway.